Matches in Nanopublications for { ?s ?p "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP697305.RAlBV95P65eOSUSim8KLkzofvOmU_eOU3Aq1KJeVkQtPc130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697305.RAlBV95P65eOSUSim8KLkzofvOmU_eOU3Aq1KJeVkQtPc130_provenance.
- NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_provenance.
- NP718824.RA7Yvt0tVZaPRhYO5zaQkJ9A5yqA-6XhFOs2umNpDahpU130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718824.RA7Yvt0tVZaPRhYO5zaQkJ9A5yqA-6XhFOs2umNpDahpU130_provenance.
- NP668089.RAab0b4yH0r5TBW0tHecdz6HEJciTxS-LWVwECK3iZM5s130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668089.RAab0b4yH0r5TBW0tHecdz6HEJciTxS-LWVwECK3iZM5s130_provenance.
- NP626074.RAPlYWWRjMi8tZ9RY85ma1wI2OFjnIRtc1u9d9yJ1VuiY130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626074.RAPlYWWRjMi8tZ9RY85ma1wI2OFjnIRtc1u9d9yJ1VuiY130_provenance.
- assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP668084.RA7bcIyPFhxr-wI-lc9XJY4GmK1pIvh9kZBn-PA5zKMFo130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668084.RA7bcIyPFhxr-wI-lc9XJY4GmK1pIvh9kZBn-PA5zKMFo130_provenance.
- NP769018.RALQAHlha4XiIpvQsI6ja73N3Au3RyHM8mMXusEKWonyo130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769018.RALQAHlha4XiIpvQsI6ja73N3Au3RyHM8mMXusEKWonyo130_provenance.
- NP769020.RAIm7R30FpdHeXUCz-S8MZcRcRiL6otJkmQAhc2opB744130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769020.RAIm7R30FpdHeXUCz-S8MZcRcRiL6otJkmQAhc2opB744130_provenance.